These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16848744)

  • 1. Vitamin D receptor agonists: opportunities and challenges in drug discovery.
    Takahashi T; Morikawa K
    Curr Top Med Chem; 2006; 6(12):1303-16. PubMed ID: 16848744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor as a drug discovery target.
    Pinette KV; Yee YK; Amegadzie BY; Nagpal S
    Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent progress of study on vitamin D analogs].
    Kittaka A; Saito N; Takano M
    Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of stereochemistry on the actions of vitamin D.
    Chiellini G; DeLuca HF
    Curr Top Med Chem; 2011; 11(7):840-59. PubMed ID: 21291397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
    Ma Y; Khalifa B; Yee YK; Lu J; Memezawa A; Savkur RS; Yamamoto Y; Chintalacharuvu SR; Yamaoka K; Stayrook KR; Bramlett KS; Zeng QQ; Chandrasekhar S; Yu XP; Linebarger JH; Iturria SJ; Burris TP; Kato S; Chin WW; Nagpal S
    J Clin Invest; 2006 Apr; 116(4):892-904. PubMed ID: 16528410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E; Finch J; Ritter C; Takahashi F
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1α,25-Dihydroxyvitamin D
    Ishizawa M; Akagi D; Yamamoto J; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and the Anticancer Activity of Vitamin D Receptor Agonists.
    Powała A; Żołek T; Brown G; Kutner A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D analogues.
    Brown AJ
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S25-39. PubMed ID: 9808141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].
    Makishima M
    Clin Calcium; 2015 Mar; 25(3):403-11. PubMed ID: 25716814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New vitamin D analogs.
    Slatopolsky E; Finch J; Brown A
    Kidney Int Suppl; 2003 Jun; (85):S83-7. PubMed ID: 12753273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic uses of vitamin D analogues.
    Brown AJ
    Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S3-S19. PubMed ID: 11689383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
    Yasuda K; Tohyama E; Takano M; Kittaka A; Ohta M; Ikushiro S; Sakaki T
    J Steroid Biochem Mol Biol; 2018 Apr; 178():333-339. PubMed ID: 29425808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
    Buchwald PC; Westin G; Akerström G
    Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in research on vitamin D analogs].
    Kubodera N
    Clin Calcium; 2006 Jul; 16(7):1167-72. PubMed ID: 16816477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D analogs as therapeutic agents: a clinical study update.
    Wu-Wong JR; Tian J; Goltzman D
    Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.